Catalyst Capital Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-10,000
| Closed | -$306K | – | 452 |
|
|
2016
Q2 | $306K | Buy |
+10,000
| New | +$306K | 0.06% | 229 |
|
|
2015
Q2 | – | Sell |
-13,600
| Closed | -$481K | – | 468 |
|
|
2015
Q1 | $481K | Buy |
13,600
+6,098
| +81% | +$216K | 0.06% | 208 |
|
|
2014
Q4 | $256K | Buy |
7,502
+2,197
| +41% | +$75K | 0.03% | 291 |
|
|
2014
Q3 | $205K | Buy |
+5,305
| New | +$205K | 0.03% | 281 |
|